CSat Investment Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $3K | Sell |
30
-2
| -6% | -$200 | ﹤0.01% | 504 |
|
2020
Q4 | $3K | Sell |
32
-7,381
| -100% | -$692K | ﹤0.01% | 501 |
|
2020
Q3 | $649K | Buy |
7,413
+1,004
| +16% | +$87.9K | 0.06% | 158 |
|
2020
Q2 | $629K | Buy |
6,409
+2,160
| +51% | +$212K | 0.08% | 140 |
|
2020
Q1 | $324K | Sell |
4,249
-102
| -2% | -$7.78K | 0.07% | 178 |
|
2019
Q4 | $386K | Buy |
4,351
+1,216
| +39% | +$108K | 0.1% | 177 |
|
2019
Q3 | $238K | Buy |
3,135
+412
| +15% | +$31.3K | 0.07% | 185 |
|
2019
Q2 | $198K | Buy |
2,723
+2,693
| +8,977% | +$196K | 0.07% | 188 |
|
2019
Q1 | $2K | Buy |
30
+4
| +15% | +$267 | ﹤0.01% | 536 |
|
2018
Q4 | $2K | Buy |
26
+13
| +100% | +$1K | ﹤0.01% | 521 |
|
2018
Q3 | $1K | Buy |
13
+2
| +18% | +$154 | ﹤0.01% | 539 |
|
2018
Q2 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 539 |
|